According to Kaback, LacY is a model for a large family of related transport proteins, many of which are associated with human disease.
"We hope that the structure of LacY will offer a useful tool by enabling scientists to understand how other membrane transport proteins work," said Kaback, a professor of physiology and microbiology, immunology and molecular genetics at the David Geffen School of Medicine at UCLA and a Howard Hughes Medical Institute investigator.
Published in the Aug. 1 edition of Science, the research findings could hold therapeutic implications for diseases such as lactose intolerance, diabetes, stroke and depression, which involve the malfunction of membrane transport proteins.
Crystallographers Jeff Abramson and So Iwata of Imperial College London co-authored the study. The work was partially supported by the National Institutes of Health.